Takeda Pharmaceutical Company Limited Share Price
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,648.00 JPY | +2.60% |
|
+3.07% | +16.81% |
| 07-24 | Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading | MT |
| 07-24 | China Merchants Starts Takeda Pharmaceutical at Buy with 6,600 Yen Price Target | MT |
| Market Cap | 9,018B 55.09B 48.39B 45B 41.29B 77.59B 5,306B 78.78B 534B 209B 2,608B 207B 202B | P/E 2027 * |
46x | P/E 2028 * | 28.6x |
|---|---|---|---|---|---|
| Enterprise Value | 12,905B 78.84B 69.24B 64.39B 59.09B 111B 7,592B 113B 765B 299B 3,732B 296B 290B | EV / Sales 2027 * |
2.77x | EV / Sales 2028 * | 2.7x |
| Free-Float |
99.26% | Yield 2027 * |
3.62% | Yield 2028 * | 3.7% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +2.60% | ||
| 1 week | +3.07% | ||
| Current month | +9.56% | ||
| 1 month | +10.66% | ||
| 3 months | +5.87% | ||
| 6 months | +10.40% | ||
| Current year | +16.81% |
| 1 week | 5,467 |  | 5,648 |
| 1 month | 5,053 | | 5,648 |
| Current year | 4,710 | | 6,033 |
| 1 year | 4,102 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 23/06/2026 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 31/03/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 31/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 31/05/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 31/12/2018 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 31/05/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/07/26 | Issuer sale | President, Japan Pharma B.U. | -1,022 | 0.0001% | ||
| 10/07/26 | Issuer sale | Director | -1,152 | 0.0001% | ||
| 10/07/26 | Issuer sale | Director | -1,152 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.60% | +3.07% | +29.84% | +28.10% | 53.64B | |
| +0.86% | +1.43% | +48.50% | +160.39% | 1,057B | |
| +1.59% | +4.09% | +55.34% | +53.96% | 624B | |
| +0.95% | +1.91% | +35.91% | +81.14% | 454B | |
| +1.60% | +6.25% | +33.95% | +29.84% | 341B | |
| -0.60% | +1.52% | +35.68% | +39.76% | 297B | |
| -0.14% | +0.60% | +16.17% | +17.53% | 262B | |
| +0.09% | -2.82% | -28.29% | -41.71% | 215B | |
| +1.22% | +2.66% | +21.87% | +59.73% | 201B | |
| -1.18% | -3.70% | +14.23% | +66.51% | 162B | |
| Average | +0.59% | +1.43% | +26.32% | +49.53% | 366.76B | |
| Weighted average by Cap. | +0.57% | +1.93% | +35.65% | +76.89% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,651B 28.41B 24.96B 23.21B 21.3B 40.02B 2,736B 40.63B 276B 108B 1,345B 107B 104B | 4,722B 28.85B 25.34B 23.56B 21.62B 40.63B 2,778B 41.25B 280B 109B 1,366B 108B 106B |
| Net income | 183B 1.12B 983M 914M 839M 1.58B 108B 1.6B 10.86B 4.24B 52.99B 4.2B 4.11B | 308B 1.88B 1.65B 1.54B 1.41B 2.65B 181B 2.69B 18.25B 7.13B 89.09B 7.06B 6.91B |
| Net Debt | 3,887B 23.74B 20.85B 19.39B 17.8B 33.44B 2,286B 33.95B 230B 89.97B 1,124B 89.13B 87.21B | 3,751B 22.91B 20.13B 18.72B 17.17B 32.27B 2,207B 32.77B 222B 86.83B 1,085B 86.02B 84.17B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | JP¥5,648.00 | +2.60% | 3,633,100 |
| 23/07/26 | JP¥5,505.00 | -0.85% | 2,920,500 |
| 22/07/26 | JP¥5,552.00 | -0.05% | 4,253,200 |
| 21/07/26 | JP¥5,555.00 | +1.37% | 5,394,200 |
| 17/07/26 | JP¥5,480.00 | +2.53% | 5,074,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
